In patients with HeFH (Fig. 2B), the HoFH-related lysophospholipid markers were also observed to be significantly elevated compared to non-FH individuals (fold change > 1.5; P < 0.05; VIP > 1.5). The gene discussed is VIP; the disease is familial hyperaldosteronism.